UBA1 and hematologic disorder: Therefore, testing for UBA1 mutations is recommended for adult patients with systemic inflammation, hematologic disorders, and vacuolation of myeloid and erythroid precursor cells to assist in the early diagnosis of the syndrome and to improve prognosis.